Comparative Pharmacokinetics of Gallic Acid, Protocatechuic Acid, and Quercitrin in Normal and Pyelonephritis Rats after Oral Administration of a Polygonum capitatum Extract

Polygonum capitatum Buch.-Ham. ex D. Don is traditionally used by Hmong for the treatment of urinary tract infections and pyelonephritis. Information regarding the pharmacokinetic behavior of the extract in the condition of pyelonephritis is lacking. In the present study, we aimed to compare the pharmacokinetic properties of gallic acid (GA), protocatechuic acid (PCA), and quercitrin (QR)—the main bioactive constituents in the herb—in normal and pyelonephritis rats. The plasma samples were collected at various time points after administration of a single dose of Polygonum capitatum extract. The plasma level of GA, PCA, and QR at the designed time points was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and drug concentration versus time plots were constructed to estimate the pharmacokinetic parameters. The AUC(0-t), AUC(0-∞), MRT(0-t), and CL of GA, PCA, and QR in pyelonephritis rats was significantly different from those of the normal rats. The results indicated that the three constituents have higher rate of uptake and slower rate of elimination in the rats with pyelonephritis, suggesting altered rate and extent of drug metabolism.

[1]  M. Jyothis,et al.  Role of antioxidant defence, renal toxicity markers and inflammatory cascade in disease progression of acute pyelonephritis in experimental rat model. , 2017, Microbial pathogenesis.

[2]  E. Morgan Regulation of Drug-Metabolizing Enzymes and Drug Metabolism by Inflammatory Responses , 2017 .

[3]  T. Nolin Drug Metabolism in Kidney Disease , 2017 .

[4]  Yang Yang,et al.  Chemical constituents from Polygonum capitatum Buch-Ham. ex D. Don , 2015 .

[5]  Yang Yang,et al.  Chemical Constituents of Polygonum capitatum , 2015, Chemistry of Natural Compounds.

[6]  Xin Zhou,et al.  An UHPLC-MS/MS method for simultaneous quantification of gallic acid and protocatechuic acid in rat plasma after oral administration of Polygonum capitatum extract and its application to pharmacokinetics. , 2015, Journal of ethnopharmacology.

[7]  T. Nolin,et al.  Effect of Experimental Kidney Disease on the Functional Expression of Hepatic Reductases , 2015, Drug Metabolism and Disposition.

[8]  Li Mi Rat model of acute pyelonephritis by simple bladder injection without laparotomy , 2015 .

[9]  Rui-jie Zhang,et al.  [Advances on pharmacokinetics of traditional Chinese medicine under disease states]. , 2015, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[10]  S. Liao,et al.  Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs. , 2014, Journal of ethnopharmacology.

[11]  Xin Zhou,et al.  Optimization of quercitrin and total flavonoids extraction from Herba Polygoni Capitati by response surface methodology , 2014, Pharmacognosy magazine.

[12]  Bo-Li Zhang,et al.  Identification and characterisation of phenolics in Polygonum capitatum by ultrahigh-performance liquid chromatography with photodiode array detection and tandem mass spectrometry. , 2013, Phytochemical analysis : PCA.

[13]  Shen Wei,et al.  Development and validation of HPLC coupled with triple quadrupole MS for the simultaneous determination of six phenolic acids, six flavonoids, and a lignan in Polygonum capitatum. , 2013, Journal of separation science.

[14]  G. Sukhikh,et al.  Inflammatory pre-conditioning of mesenchymal multipotent stromal cells improves their immunomodulatory potency in acute pyelonephritis in rats. , 2013, Cytotherapy.

[15]  Wang Pei-qing Antibacterial Activities of Nine Polygonaceae Plants , 2013 .

[16]  B. Moorthy,et al.  Drug disposition in pathophysiological conditions. , 2012, Current drug metabolism.

[17]  O. Ozturk,et al.  Effect of Thymoquinone on Oxidative Stress in Escherichia coli-Induced Pyelonephritis in Rats. , 2011, Current therapeutic research, clinical and experimental.

[18]  Ying Xiong,et al.  Antibacterial and anti-inflammatory effects of extracts and fractions from Polygonum capitatum. , 2011, Journal of ethnopharmacology.

[19]  Richard Colgan,et al.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Wang Qiu-hong Effects of Anti-infective Part of Filifolium sibiricum on Pyelonephritis in Rats , 2011 .

[21]  V. Mohan,et al.  Gallic acid protects RINm5F β‐cells from glucolipotoxicity by its antiapoptotic and insulin‐secretagogue actions , 2010, Phytotherapy research : PTR.

[22]  Kang Wen-yi,et al.  Antioxidant Activity of Polygonum capitatum , 2010 .

[23]  P. S. M. Prince,et al.  Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. , 2009, Chemico-biological interactions.

[24]  Lei Ding-he Study of treatment with ceftazidime combine with Sanjin tablet on acute pyelonephritis , 2009 .

[25]  Wang Liu Clinical Observation on the Treatment of Pyelonephritis with Cefoperazone Sulbactam , 2009 .

[26]  Yang Yang,et al.  Study on chemical constituents of Polygonum capitatum Buch.-Ham. ex D. Don(I) , 2009 .

[27]  S. Çelik,et al.  Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats. , 2008, Urology.

[28]  He Wei-ming Establishment and Observation of Rats Model with Acute Pyelonephritis , 2007 .

[29]  S. Çelik,et al.  Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in rats , 2007, Molecular and Cellular Biochemistry.

[30]  C. Jun,et al.  Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  T. A. Richardson,et al.  Regulation of drug-metabolizing enzymes and transporters in inflammation. , 2006, Annual review of pharmacology and toxicology.

[32]  Vinod P. Shah,et al.  Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.

[33]  A. Melman,et al.  Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats. , 1999, The Journal of urology.

[34]  H. Q. V. Ufford,et al.  Anti-Inflammatory Activity of Gallic Acid , 1992, Planta medica.

[35]  P. Larsson,et al.  An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats. , 1980, Journal of clinical pathology.